Cargando…
Emerging Preclinical Applications of Humanized Mouse Models in the Discovery and Validation of Novel Immunotherapeutics and Their Mechanisms of Action for Improved Cancer Treatment
Cancer therapeutics have undergone immense research over the past decade. While chemotherapies remain the mainstay treatments for many cancers, the advent of new molecular techniques has opened doors for more targeted modalities towards cancer cells. Although immune checkpoint inhibitors (ICIs) have...
Autores principales: | Karnik, Isha, Her, Zhisheng, Neo, Shu Hui, Liu, Wai Nam, Chen, Qingfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305679/ https://www.ncbi.nlm.nih.gov/pubmed/37376049 http://dx.doi.org/10.3390/pharmaceutics15061600 |
Ejemplares similares
-
Preclinical mouse models for immunotherapeutic and non-immunotherapeutic drug development for pancreatic ductal adenocarcinoma
por: He, Mengni, et al.
Publicado: (2020) -
Humanized Mouse Models for the Study of Hepatitis C and Host Interactions
por: Yong, Kylie Su Mei, et al.
Publicado: (2019) -
Preclinical and Clinical Immunotherapeutic Strategies in Epithelial Ovarian Cancer
por: Martinez, Alejandra, et al.
Publicado: (2020) -
Immunotherapeutic Strategies for Gastric Carcinoma: A Review of Preclinical and Clinical Recent Development
por: Abozeid, Mohamed, et al.
Publicado: (2017) -
Humanized Mice as Unique Tools for Human-Specific Studies
por: Yong, Kylie Su Mei, et al.
Publicado: (2018)